应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00013 和黄医药
休市中 04-19 16:08:35
26.000
-0.100
-0.38%
最高
26.250
最低
25.050
成交量
269.90万
今开
25.800
昨收
26.100
日振幅
4.60%
总市值
226.53亿
流通市值
226.53亿
总股本
8.71亿
成交额
6,947万
换手率
0.31%
流通股本
8.71亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
和黄医药04月19日遭主力抛售300万元 环比增加1775.00%
自选股智能写手 · 04-19 16:15
和黄医药04月19日遭主力抛售300万元 环比增加1775.00%
和黄医药04月15日主力资金流出474万元 连续3日减仓
自选股智能写手 · 04-15
和黄医药04月15日主力资金流出474万元 连续3日减仓
南向资金4月12日净卖出和黄医药41.00万股 连续3日减持
自选股智能写手 · 04-15
南向资金4月12日净卖出和黄医药41.00万股 连续3日减持
和黄医药(US ADR)下跌2.16%,报17.7美元/股
金融界 · 04-13
和黄医药(US ADR)下跌2.16%,报17.7美元/股
和黄医药4月11日遭南向资金减持117.47万股
自选股智能写手 · 04-12
和黄医药4月11日遭南向资金减持117.47万股
和黄医药04月10日主力资金流入483万元 连续3日加仓
自选股智能写手 · 04-10
和黄医药04月10日主力资金流入483万元 连续3日加仓
和黄医药(US ADR)上涨5.99%,报17.88美元/股
金融界 · 04-09
和黄医药(US ADR)上涨5.99%,报17.88美元/股
平安证券:维持和黄医药(00013)“推荐”评级 2023年业绩符合预期
智通财经 · 04-09
平安证券:维持和黄医药(00013)“推荐”评级 2023年业绩符合预期
和黄医药04月09日获主力加仓419万元 环比增加481.94%
自选股智能写手 · 04-09
和黄医药04月09日获主力加仓419万元 环比增加481.94%
港股异动 | 和黄医药(00013)现涨近6% 公司于AACR年会公布数据 呋喹替尼美国上市后放量迅速
智通财经 · 04-09
港股异动 | 和黄医药(00013)现涨近6% 公司于AACR年会公布数据 呋喹替尼美国上市后放量迅速
和黄医药(00013)上涨5.03%,报28.2元/股
金融界 · 04-09
和黄医药(00013)上涨5.03%,报28.2元/股
和黄医药(00013)股价上升5.028%,现价港币$28.2
阿斯达克财经 · 04-09
和黄医药(00013)股价上升5.028%,现价港币$28.2
和黄医药(00013.HK)将于美国癌症研究协会年会披露数项研究数据
阿斯达克财经 · 04-05
和黄医药(00013.HK)将于美国癌症研究协会年会披露数项研究数据
和黄医药(00013)将于美国癌症研究协会(AACR)2024年年会公布数项研究数据
智通财经 · 04-05
和黄医药(00013)将于美国癌症研究协会(AACR)2024年年会公布数项研究数据
和黄医药04月05日主力资金流出483万元 连续5日减仓
自选股智能写手 · 04-05
和黄医药04月05日主力资金流出483万元 连续5日减仓
和黄医药(00013)下跌5.13%,报25.9元/股
金融界 · 04-05
和黄医药(00013)下跌5.13%,报25.9元/股
和黄医药(00013)股价下跌5.128%,现价港币$25.9
阿斯达克财经 · 04-05
和黄医药(00013)股价下跌5.128%,现价港币$25.9
和黄医药04月03日遭主力抛售1518万元 环比增加1497.89%
自选股智能写手 · 04-03
和黄医药04月03日遭主力抛售1518万元 环比增加1497.89%
南向资金4月2日净买入和黄医药30.40万股 连续3日增持
自选股智能写手 · 04-03
南向资金4月2日净买入和黄医药30.40万股 连续3日增持
和黄医药04月02日主力资金流出95万元 连续3日减仓
自选股智能写手 · 04-02
和黄医药04月02日主力资金流出95万元 连续3日减仓
加载更多
公司概况
公司名称:
和黄医药
所属市场:
SEHK
上市日期:
--
主营业务:
和黄医药(中国)有限公司(原名:和黄中国医药科技有限公司)是一家主要从事药品制造及销售的投资控股公司。连同其附属公司,该公司通过两个分部经营业务。肿瘤及免疫业务分部从事发现、开发和商业化用于治疗癌症和免疫性疾病的靶向疗法和免疫疗法,包括涵盖药物发现、开发、生产及监管职能的研发活动,以及支持研发业务的行政活动,还包括通过研发活动开发的药物的销售、推广、生产及分销。其他业务分部从事其他商业化业务,包括其他处方药物及非处方药物以及消费保健品的销售、推广、生产及分销。
发行价格:
--
{"stockData":{"symbol":"00013","market":"HK","secType":"STK","nameCN":"和黄医药","latestPrice":26,"timestamp":1713514115025,"preClose":26.1,"halted":0,"volume":2699047,"delay":0,"floatShares":871256270,"shares":871256270,"eps":0.92890596,"marketStatus":"休市中","marketStatusCode":7,"change":-0.1,"latestTime":"04-19 16:08:35","open":25.8,"high":26.25,"low":25.05,"amount":69465385,"amplitude":0.045977,"askPrice":26,"askSize":7000,"bidPrice":25.95,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":0.9289059440833268,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"listingDate":1624982400000,"adjPreClose":26.1,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":1.063496951934979,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00013/","defaultTab":"news","newsList":[{"id":"2428172687","title":"和黄医药04月19日遭主力抛售300万元 环比增加1775.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428172687","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428172687?lang=zh_cn&edition=full","pubTime":"2024-04-19 16:15","pubTimestamp":1713514507,"startTime":"0","endTime":"0","summary":"04月19日, 和黄医药股价跌0.38%,报收26.00元,成交金额6946万元,换手率0.31%,振幅4.60%,量比1.06。和黄医药今日主力资金净流出300万元,上一交易日主力净流出16万元,今日环比增加1775.00%。该股近5个交易日下跌9.84%,主力资金累计净流出246万元;近20日主力资金累计净流出1342万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191615128b3a1bfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191615128b3a1bfc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427025170","title":"和黄医药04月15日主力资金流出474万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2427025170","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427025170?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:16","pubTimestamp":1713168976,"startTime":"0","endTime":"0","summary":"04月15日, 和黄医药股价跌2.59%,报收28.20元,成交金额7138万元,换手率0.29%,振幅3.97%,量比0.77。和黄医药今日主力资金净流出474万元,连续3日净流出,上一交易日主力净流出238万元,今日环比增加99.16%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为33.33%,平均跌幅为2.39%。该股近5个交易日上涨5.03%,主力资金累计净流入58万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入15万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161638877e8ea0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161638877e8ea0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427091775","title":"南向资金4月12日净卖出和黄医药41.00万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427091775","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427091775?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:31","pubTimestamp":1713144667,"startTime":"0","endTime":"0","summary":"4月12日,南向资金减持和黄医药41.00万股连续3日减持。截止当日收盘,港股通共持有和黄医药15087.96万股,占流通股17.31%。和黄医药近5个交易日上涨10.71%,港股通累计减持294.22万股;近20个交易日上涨13.98%,港股通累计增持651.18万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150943538b23b564&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150943538b23b564&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427751466","title":"和黄医药(US ADR)下跌2.16%,报17.7美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427751466","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2427751466?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:50","pubTimestamp":1712947840,"startTime":"0","endTime":"0","summary":"4月13日,和黄医药(US ADR)(HCM)盘中下跌2.16%,截至02:50,报17.7美元/股,成交80.99万美元。财务数据显示,截至2023年12月31日,和黄医药(US ADR)收入总额8.38亿美元,同比增长96.52%;归母净利润1.01亿美元,同比增长127.93%。大事提醒:4月8日,和黄医药(US ADR)2023年四季度累计回购金额907.1万美元。5月22日,和黄医药(US ADR)将披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/13025040224624.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426721249","title":"和黄医药4月11日遭南向资金减持117.47万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426721249","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426721249?lang=zh_cn&edition=full","pubTime":"2024-04-12 09:31","pubTimestamp":1712885465,"startTime":"0","endTime":"0","summary":"4月11日,南向资金减持和黄医药117.47万股。截止当日收盘,港股通共持有和黄医药15128.96万股,占流通股17.35%。和黄医药近5个交易日上涨5.49%,港股通累计减持272.47万股;近20个交易日上涨21.52%,港股通累计增持720.13万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120941298b13c844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120941298b13c844&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426555184","title":"和黄医药04月10日主力资金流入483万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2426555184","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426555184?lang=zh_cn&edition=full","pubTime":"2024-04-10 16:15","pubTimestamp":1712736943,"startTime":"0","endTime":"0","summary":"04月10日, 和黄医药股价跌1.55%,报收28.50元,成交金额8728万元,换手率0.35%,振幅2.76%,量比0.79。和黄医药今日主力资金净流入483万元,连续3日净流入,上一交易日主力净流入419万元,今日环比增加15.27%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为38.46%,平均涨幅为4.75%。该股近5个交易日上涨6.53%,主力资金累计净流出1026万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2520万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410161605875f6623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410161605875f6623&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426903361","title":"和黄医药(US ADR)上涨5.99%,报17.88美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426903361","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426903361?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:00","pubTimestamp":1712671214,"startTime":"0","endTime":"0","summary":"4月9日,和黄医药(US ADR)(HCM)盘中上涨5.99%,截至22:00,报17.88美元/股,成交245.14万美元。财务数据显示,截至2023年12月31日,和黄医药(US ADR)收入总额8.38亿美元,同比增长96.52%;归母净利润1.01亿美元,同比增长127.93%。大事提醒:4月8日,和黄医药(US ADR)2023年四季度累计回购金额907.1万美元。5月22日,和黄医药(US ADR)将披露2024财年一季报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/09220040170551.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426154887","title":"平安证券:维持和黄医药(00013)“推荐”评级 2023年业绩符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2426154887","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426154887?lang=zh_cn&edition=full","pubTime":"2024-04-09 16:49","pubTimestamp":1712652542,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,平安证券发布研究报告称,考虑到公司上市产品适应症仍在拓展,同时在研管线丰富,管线估值有望进一步提升,维持和黄医药“推荐”评级,预计2024-2026年主营业务收入分别为6.71、8.61、10.27亿美元,净利润分别为-1.07、0.2、0.95亿美元,与之前保持一致。平安证券主要观点如下:核心产品销售额保持较快增长,呋喹替尼美国上市后放量迅速。2)呋喹替尼国内二线胃癌适应症23年4月获CDE受理,有望于24年获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099998.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426156405","title":"和黄医药04月09日获主力加仓419万元 环比增加481.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426156405","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426156405?lang=zh_cn&edition=full","pubTime":"2024-04-09 16:16","pubTimestamp":1712650580,"startTime":"0","endTime":"0","summary":"04月09日, 和黄医药股价涨7.82%,报收28.95元,成交金额1.99亿元,换手率0.80%,振幅9.87%,量比2.38。和黄医药今日主力资金净流入419万元,上一交易日主力净流入72万元,今日环比增加481.94%。该股近5个交易日上涨8.22%,主力资金累计净流出1603万元;近20日主力资金累计净流入2531万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091616538758d526&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091616538758d526&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426071539","title":"港股异动 | 和黄医药(00013)现涨近6% 公司于AACR年会公布数据 呋喹替尼美国上市后放量迅速","url":"https://stock-news.laohu8.com/highlight/detail?id=2426071539","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426071539?lang=zh_cn&edition=full","pubTime":"2024-04-09 10:22","pubTimestamp":1712629346,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,和黄医药(00013)现涨近6%,截至发稿,涨5.21%,报28.25港元,成交额5869.12万港元。消息面上,和黄医药此前公布,将于2024年4月5日至10日,在美国加利福尼亚州圣地亚哥召开的美国癌症研究协会(AACR)2024年年会上公布自主研发的化合物的数项研究的最新及更新后的数据。平安证券指出,呋喹替尼在全球三线结直肠癌市场保持领导地位,美国上市后放量迅速;呋喹替尼二线胃癌适应症获批可期,国内销售额峰值有望超20亿元;在研管线持续发力,多款重磅产品新适应症获批预期有望不断催化公司价值提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099793.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426190209","title":"和黄医药(00013)上涨5.03%,报28.2元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426190209","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426190209?lang=zh_cn&edition=full","pubTime":"2024-04-09 10:14","pubTimestamp":1712628850,"startTime":"0","endTime":"0","summary":"4月9日,和黄医药(00013)盘中上涨5.03%,截至10:14,报28.2元/股,成交5017.5万元。和黄医药(中国)有限公司是一家专注于全球市场的创新型医药研发企业,主要业务包括研发、生产、营销和经销抗肿瘤药物、处方药和消费保健产品。公司在全球范围内拥有多个上市药物,并在纳斯达克全球精选市场、香港交易所以及伦敦证交所的AIM市场上市。截至2023年年报,和黄医药营业总收入59.35亿元、净利润7.14亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/09101440160211.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426907409","title":"和黄医药(00013)股价上升5.028%,现价港币$28.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2426907409","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426907409?lang=zh_cn&edition=full","pubTime":"2024-04-09 10:14","pubTimestamp":1712628840,"startTime":"0","endTime":"0","summary":"[上升股]和黄医药(00013) 股价在上午10:14比前收市价上升5.028%,现股价为港币$28.2。至目前为止,今日最高价为$28.2,而最低价为$26.6。总成交量为180.353万股,总成交金额为港币$5.016千万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404091252/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2425623531","title":"和黄医药(00013.HK)将于美国癌症研究协会年会披露数项研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2425623531","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2425623531?lang=zh_cn&edition=full","pubTime":"2024-04-05 16:47","pubTimestamp":1712306820,"startTime":"0","endTime":"0","summary":"和黄医药公布,将于4月5至10日在美国加利福尼亚州圣地亚哥召开的美国癌症研究协会 2024年年会上公布公司自主研发的化合物的数项研究的最新及更新后的数据。HMPL-506的I期研究计划于2024年下半年展开。新型CD38靶向抗体偶联药物 HMPL-A067 的初步临床前数据亦将公布,这是一种以达雷妥尤单抗与细胞毒类载荷一甲基澳瑞他汀 E 通过新型连接子偶联的药物。其在多个B细胞恶性肿瘤模型大中,均显示出显著优于达雷妥尤单抗的抗肿瘤活性。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220520173823854_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220520173823854_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1340371/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2425539504","title":"和黄医药(00013)将于美国癌症研究协会(AACR)2024年年会公布数项研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2425539504","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2425539504?lang=zh_cn&edition=full","pubTime":"2024-04-05 16:36","pubTimestamp":1712306177,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和黄医药 发布公告,该集团今日宣布将于 2024 年 4 月 5 日至 10 日在美国加利福尼亚州圣地亚哥召开的美国癌症研究协会2024 年年会上公布和黄医药自主研发的化合物的数项研究的最新及更新后的数据。HMPL-506 的 I 期研究计划于 2024 年下半年展开。其在多个 B 细胞恶性肿瘤模型中,包括达雷妥尤单抗耐药的肿瘤模型中,均显示出显著优于达雷妥尤单抗的抗肿瘤活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1098839.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2425536738","title":"和黄医药04月05日主力资金流出483万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2425536738","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425536738?lang=zh_cn&edition=full","pubTime":"2024-04-05 16:15","pubTimestamp":1712304954,"startTime":"0","endTime":"0","summary":"04月05日, 和黄医药股价跌4.21%,报收26.15元,成交金额5655万元,换手率0.25%,振幅5.49%,量比0.71。和黄医药今日主力资金净流出483万元,连续5日净流出,上一交易日主力净流出1518万元,今日环比减少68.18%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为66.67%,平均跌幅为1.53%。该股近5个交易日下跌1.69%,主力资金累计净流出2565万元,其中4个交易日为股价上涨时净流出;近20日主力资金累计净流入2574万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404051616138af386b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404051616138af386b3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425649305","title":"和黄医药(00013)下跌5.13%,报25.9元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425649305","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425649305?lang=zh_cn&edition=full","pubTime":"2024-04-05 10:23","pubTimestamp":1712283819,"startTime":"0","endTime":"0","summary":"4月5日,和黄医药(00013)盘中下跌5.13%,截至10:23,报25.9元/股,成交2282.83万元。和黄医药(中国)有限公司主要从事药品的制造和销售,特别专注于创新型医药的研发,已经在全球开展了12种临床阶段的创新抗癌药物的研究。公司在中国市场建立了深入的商业平台,生产、营销和经销自主研发的创新肿瘤药物、处方药和消费保健产品,并正在将商业化版图扩展到美国和欧洲。截至2023年年报,和黄医药营业总收入59.35亿元、净利润7.14亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/05102340128787.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425305193","title":"和黄医药(00013)股价下跌5.128%,现价港币$25.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2425305193","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2425305193?lang=zh_cn&edition=full","pubTime":"2024-04-05 10:23","pubTimestamp":1712283780,"startTime":"0","endTime":"0","summary":"[下跌股]和黄医药(00013) 股价在上午10:23比前收市价下跌5.128%,现股价为港币$25.9。至目前为止,今日最高价为$27.3,而最低价为$25.9。总成交量为86.8万股,总成交金额为港币$2.283千万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404051519/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424983598","title":"和黄医药04月03日遭主力抛售1518万元 环比增加1497.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424983598","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424983598?lang=zh_cn&edition=full","pubTime":"2024-04-03 16:17","pubTimestamp":1712132222,"startTime":"0","endTime":"0","summary":"04月03日, 和黄医药股价涨1.87%,报收27.30元,成交金额1.41亿元,换手率0.60%,振幅5.60%,量比1.89。和黄医药今日主力资金净流出1518万元,连续4日净流出,上一交易日主力净流出95万元,今日环比增加1497.89%。近一年数据显示,该股主力连续4日净流出后,次日下跌概率为16.67%,平均跌幅为0.34%。该股近5个交易日上涨2.61%,主力资金累计净流出2066万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2500万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404031618158aec8871&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404031618158aec8871&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424806078","title":"南向资金4月2日净买入和黄医药30.40万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2424806078","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424806078?lang=zh_cn&edition=full","pubTime":"2024-04-03 09:31","pubTimestamp":1712107866,"startTime":"0","endTime":"0","summary":"4月2日, 南向资金增持和黄医药30.40万股,连续3日增持。截止当日收盘,港股通共持有和黄医药15401.43万股,占流通股17.67%。和黄医药近5个交易日上涨2.49%,港股通累计增持10.20万股;近20个交易日上涨11.20%,港股通累计增持1159.83万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040309403787d80a15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040309403787d80a15&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424615110","title":"和黄医药04月02日主力资金流出95万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2424615110","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424615110?lang=zh_cn&edition=full","pubTime":"2024-04-02 16:15","pubTimestamp":1712045709,"startTime":"0","endTime":"0","summary":"04月02日, 和黄医药股价涨0.19%,报收26.80元,成交金额8066万元,换手率0.35%,振幅5.23%,量比0.93。和黄医药今日主力资金净流出95万元,连续3日净流出,上一交易日主力净流出301万元,今日环比减少68.44%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为35.29%,平均跌幅为2.39%。该股近5个交易日上涨2.68%,主力资金累计净流出617万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入3929万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040216152087d46960&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040216152087d46960&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hutch-med.com","stockEarnings":[{"period":"1week","weight":-0.1019},{"period":"1month","weight":-0.0563},{"period":"3month","weight":0.153},{"period":"6month","weight":-0.0388},{"period":"1year","weight":-0.0019},{"period":"ytd","weight":-0.0941}],"compareEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.0193},{"period":"3month","weight":0.0598},{"period":"6month","weight":-0.0552},{"period":"1year","weight":-0.2046},{"period":"ytd","weight":-0.0483}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和黄医药(中国)有限公司(原名:和黄中国医药科技有限公司)是一家主要从事药品制造及销售的投资控股公司。连同其附属公司,该公司通过两个分部经营业务。肿瘤及免疫业务分部从事发现、开发和商业化用于治疗癌症和免疫性疾病的靶向疗法和免疫疗法,包括涵盖药物发现、开发、生产及监管职能的研发活动,以及支持研发业务的行政活动,还包括通过研发活动开发的药物的销售、推广、生产及分销。其他业务分部从事其他商业化业务,包括其他处方药物及非处方药物以及消费保健品的销售、推广、生产及分销。","exchange":"SEHK","name":"和黄医药","nameEN":"HUTCHMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和黄医药(00013)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和黄医药(00013)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和黄医药,00013,和黄医药股票,和黄医药股票老虎,和黄医药股票老虎国际,和黄医药行情,和黄医药股票行情,和黄医药股价,和黄医药股市,和黄医药股票价格,和黄医药股票交易,和黄医药股票购买,和黄医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和黄医药(00013)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和黄医药(00013)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}